Cell type specificity of lung cancer associated with arsenic ingestion

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 4, 2004, Pages 638-643

  Guo, How Ran ^a,e   Wang, Nai San ^a,b   Hu, Howard ^c,d   Monson, Richard R ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CARCINOGEN; DRINKING WATER;

ADENOCARCINOMA; ADULT; AGE; AGED; ARSENIC POISONING; ARTICLE; CANCER REGISTRY; CELL TYPE; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; HUMAN; INGESTION; INHALATION; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; TAIWAN;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARSENIC; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; TAIWAN; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 2942575885     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hutchinson J. Arsenic cancer. Br Med J, 1887;2:1280-1.
2. Yeh S. Relative incidence of skin cancer in Chinese in Taiwan: with special reference to arsenical cancer. Natl Cancer Inst Monogr, 1963;10:81-107.
3. Tseng W-P, Chu H-M, How S-H, Fong J-M, Lin C-S, Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst, 1968;40:453-63.
4. Chen C-J, Kuo T-L, Wu M-M. Arsenic and cancers. Lancet, 1988;1:414-5.
5. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol, 1989;130:1123-32.
6. Chen C-J, Wang C-J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res, 1990;50:5470-4.
7. Guo H-R, Chen C-J, Greene HL. Arsenic in drinking water and cancers: a descriptive review of Taiwan studies. In: Chappell WR, Abernathy CO, Cothern CR, editors. Arsenic: exposure and health. Northwood: Science and Technology Letters; 1994. p. 129-38.
8. Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology, 1997;8:545-50.
9. Besuschio SC, Prez Desanzo AC, Croci M. Epidemiological association between arsenic and cancer in Argentina. Biol Trace Elem Res, 1980;2:41-55.
10. Koh E, Kondoh N, Kaihara H, Fujioka H, Kitamura K. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic. Eur J Urol, 1989;16:398-400.
11. Nomura Y, Nojiri A, Kudo S. Two cases of transitional cell carcinoma of urinary tract in patients with chronic arsenic poisoning. J Kumamoto Med Sci, 1986;60:13-24.
12. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am J Epidemiol, 1995;141:198-209.
13. Chiou H-Y, Chiuo S-T, Hsu Y-H, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol, 2001;153:411-8.
14. Guo H-R, Yu H-S, Hu H, Monson RR. Arsenic in drinking water and skin cancer: cell-type specificity. Cancer Cause Control, 2001;12:909-16.
15. Sommers SC, McManus RG. Multiple arsenical cancers of skin and internal organs. Cancer, 1952;6:347-59.
16. Environmental Protection Agency. National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring; Final rule. Fed Reg, 2001;66:6976-7066.
17. Morales KH, Ryan L, Kuo T-L, Wu M-M, Chen C-J. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect, 2000;108:655-61.
18. Lo M-C, Hsen Y-C, Lin B-K. Second report on the investigation of arsenic content in underground water in Taiwan. Taichung, Taiwan: Taiwan Provincial Institute of Environmental Sanitation; 1977.
19. World Health Organization. International classification of diseases for oncology, 1st ed. Geneva, Switzerland: World Health Organization; 1976.
20. Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol, 1992;135:462-76.
21. Cuzick J, Sasieni P, Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol, 1992;136:417-21.
22. Lüchtrath H. The consequences of chronic arsenic poisoning among Moselle wine growers. J Cancer Res Clin Oncol, 1983;105:173-82.
23. Nakadaira H, Endoh K, Katagiri M, Yamamoto M. Elevated mortality from lung cancer associated with arsenic exposure for a limited duration. J Occup Environ Med, 2002;44:291-9.
24. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology, 2000;11:673-9.
25. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol, 1998;27:561-9.
26. Luo FJ, Luo ZD, Ma L. A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia. Chin J Epidemiol, 1995;16:289-91.
27. Hotta N. Clinical aspects of chronic arsenic poisoning due to environmental and occupational pollution in and around a small refining spot. Jan J Cons Med, 1989;53:49-70.
28. Morita T. A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world. Jpn J Can Res, 2002;93:15-23.
29. Newman JA, Archer VE, Saccomanno G, et al. Histological types of bronchogenic carcinoma among members of copper-mining and smelting communities. Ann NY Acad Sci, 1976;217:260-8.
30. Axelson O, Dahlgren E, Jansson C-D, Rehnlund SO. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Ind Med, 1978;35:8-15.
31. Wicks MJ, Archer VE, Auerbach O, Kuschner M. Arsenic exposure in a copper smelter as related to histological type of lung cancer. Am J Ind Med, 1981;2:25-31.
32. Pershagen G, Bergman F, Klominek J, Damber L, Wall S. Histological types of lung cancer among smelter workers exposed to arsenic. Br J Ind Med, 1987;44:454-8.
33. Chiou H-I, Hsueh Y-M, Liaw K-F, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res, 1995;55:1296-300.
34. Tsai S-F. Ecological correlation study on major risk factors of various malignant neoplasms in Taiwan; 1972-1983 [Master Thesis]. National Taiwan University; 1987.
35. Guo H-R. Arsenic in drinking water and skin cancer: comparison among studies based on cancer registry, death certificates, and physical examinations. In: Abernathy CO, Calderon RL, Chappell WR, editors. Arsenic: exposure and health effects. London: Chapman & Hall; 1997. p. 243-59.
36. Guo H-R. Dose-response relation between arsenic in drinking water and mortality of bladder cancers. Chin J Public Health (Taipei), 1999;18:s134-9.
37. Guo H-R, Tseng Y-C. Arsenic in drinking water and bladder cancer: comparison between studies based on cancer registry and death certificates. Environ Geochem Health, 2000;22:83-91.